AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

TERUMO ANNOUNCES ACQUISITION OF MICROVENTION.

AsiaPulse News

| March 01, 2006 | COPYRIGHT 2006 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(Full text of a statement. Contact details below.)

TOKYO--(BUSINESS WIRE)--Feb. 28, 2006--Terumo Corporation (Shibuya-ku, Tokyo Japan; CEO Takashi Wachi), a leading provider of general hospital, cardiac and vascular, and home healthcare products, today announced that it has entered into a definitive agreement to acquire MicroVention Inc. (California, USA), a privately held medical device company focused on endovascular coils and related products for the treatment of cerebral aneurysms. A majority of MicroVention's shareholders have agreed to vote in favor of the transaction and it is expected to close by March 31, 2006 subject to the required regulatory clearance.

Founded in 1997 and headquartered in Aliso Viejo, California, MicroVention develops and commercializes novel and proprietary hydrogel-coated and bare platinum coils and related devices for the minimally invasive, endovascular treatment of cerebral vascular aneurysms. MicroVention's HydroCoil(R) Embolic System and MicroPlex(TM) coil system are based on best of breed technology and have proved to be highly effective for the treatment of cerebral aneurysms. In addition, MicroVention recently launched its V-Trak detachment system, a device used to smoothly detach coils from the delivery device in the brain. MicroVention markets and sells its products worldwide through its direct sales force and distributor network.

The worldwide market for the endovascular treatment of cerebral aneurysms, currently estimated at over $200M for endovascular coils, is expected to show a double-digit growth over the next several years. Historically, cerebral aneurysms were treated via a surgical clipping procedure which required a craniotomy. These procedures carry a significant risk and require lengthy patient recovery periods. In an endovascular coiling procedure, vascular access is gained by the femoral artery, through which guidewires and catheters are placed and fed to the site of the cerebral aneurysm. Endovascular treatment of cerebral aneurysms is substantially less invasive than surgical clipping with improved patient outcomes.

"As Terumo continues to ...

Related articles from newspapers, magazines, journals, and more
MicroVention to Be Acquired by Terumo Corporation.
Press release article from: PR Newswire February 28, 2006 700+ words
...PRNewswire/ -- MicroVention, Inc., a leading...by Tokyo-based Terumo Corporation, an international...privately-held MicroVention is expected to close...cerebral aneurysms. MicroVention sells its products...countries. About Terumo Corporation Terumo Corporation...
MicroVention and Terumo Corporation Announce Completion of Merger.
Press release article from: PR Newswire March 30, 2006 700+ words
...PRNewswire/ -- MicroVention, Inc., a leading...with Tokyo-based Terumo Corporation, an international...privately-held MicroVention, which was announced...cerebral aneurysms. MicroVention sells its products...countries. About Terumo Corporation Terumo ...
Terumo Corporation - Financial and Strategic Analysis Review.
Press release article from: M2 Presswire April 8, 2009 700+ words
...companiesandmarkets.com: Terumo Corporation - Financial and Strategic Analysis...companiesandmarkets.com adds new report: Terumo Corporation - Financial and Strategic Analysis Review Terumo Corporation - Financial and Strategic Analysis...
Terumo Corporation Acquires Cardiovascular Business From 3M.
Press release article from: Business Wire April 15, 1999 700+ words
...BUSINESS WIRE)--April 15, 1999-- Terumo Corporation (HQ: Tokyo, CEO:T. Wachi...NJ, a wholly owned subsidiary of Terumo Corporation, Japan). 1. Outline of 3M CardioVascular...cardiovascular market place. -0- TERUMO CORPORATION Date of Establishment: September...
The Terumo Corporation Strategic Analysis Profile Is A Comprehensive Profile Of...
Press release article from: M2 Presswire March 19, 2008 700+ words
...2008-Research and Markets: The Terumo Corporation Strategic Analysis Profile Is A Comprehensive...has announced the addition of "Terumo Corporation Strategic Analysis Profile" to their...latest market information and trends. Terumo Corporation Strategic Analysis Profile REPORT...
Research and Markets: The Terumo Corporation Strategic Analysis Profile Is a...
Press release article from: Business Wire March 19, 2008 700+ words
...announced the addition of "Terumo Corporation Strategic Analysis Profile...This report examines the Terumo Corporation's business structure...information and trends. Terumo Corporation Strategic Analysis Profile...
LaBarge Receives $1.7 Million in Orders from Terumo Corporation for Flexible...
Press release article from: PR Newswire May 10, 2000 700+ words
...million in orders from the Terumo Corporation, Somerset, N.J...circuit wafers for the Terumo Corporation for approximately 10...Corporation is a division of Terumo Corporation, a Tokyo-based company...
Terumo Corporation
Reference information from: International Directory of Company Histories January 1, 2003 700+ words
Terumo Corporation 44-1, 2-chome Hatagaya, Shibuya-ku Tokyo 151-0072 Japan...and Electrotherapeutic Apparatus Manufacturing Based in Tokyo, Terumo Corporation is Japan ’ s largest manufacturer of medical supplies...
For more facts and information, see all results

Source: HighBeam Research, TERUMO ANNOUNCES ACQUISITION OF MICROVENTION.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA